ArticleClinical cancer research : an official journal of the American Association for Cancer Research2020

Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK Inhibition as an Effective Strategy.

Anthony R Mato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.